Fundraising FoxCBA Pharma
Lexington, US · Founded 2012 · Nevada corporation
Find your way into CBA Pharma
Sign up to see every warm intro you have to CBA Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CBA Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
GP
George P. Julius, Jr.Executive
SW
Stephen WhitmanExecutive
LC
Louis CarmichaelExecutive
SL
Shelden LeBronExecutive
LS
Lawrence S. MartiniExecutive
RK
Robert K. Oldham, MDExecutive
SM
Scott McKinneyExecutive
BD
Beth Diane GudemanExecutive
WM
W. Michael PutnamExecutive
Board
RG
Robert Granacher, Jr., MD, MBABoard director
Reported raises · per SEC filings
Form D private placements$639.1K disclosed across 2 rounds · 2012–2015
▶$100KraisedJan 2015 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedJan 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George P. Julius, Jr.Executive Officer, Director
- Stephen WhitmanExecutive Officer, Director
- Louis CarmichaelExecutive Officer
- Shelden LeBronExecutive Officer
- Lawrence S. MartiniExecutive Officer
- Robert K. Oldham, MDExecutive Officer
- Scott McKinneyExecutive Officer, Director
- Beth Diane GudemanExecutive Officer, Director, Promoter
- W. Michael PutnamExecutive Officer, Director, Promoter
- Robert Granacher, Jr., MD, MBADirector
- Offering amount
- $20M
- Amount sold
- $100K
- Proceeds to insiders
- $500K
- First sale
- Jan 2015
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$539.1KraisedFeb 2012 · 41 investors · BiotechnologyRule 506(b)
▶$539.1KraisedFeb 2012 · 41 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott D. McKinneyExecutive Officer, Director
- Stephen L. WhitmanDirector
- W. Michael PutnamExecutive Officer, Director, Promoter
- Beth GudemanExecutive Officer, Director, Promoter
- Lawrence S. MartiniExecutive Officer
- Shelden LeBronExecutive Officer
- Robert P. Granacher, Jr., MD, MBADirector
- George P. Julius, Jr.Executive Officer, Director
- Robert K. Oldham, MDExecutive Officer
- Offering amount
- $20M
- Amount sold
- $539.1K
- Proceeds to insiders
- $450K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CBA Pharma raised?
- CBA Pharma has disclosed $639.1K raised across 2 rounds.
- Where is CBA Pharma headquartered?
- CBA Pharma is headquartered in Lexington, US.